Modulation of immune system via anti-inflammatory cytokine secretion by mesenchymal stem cell activity

This entry does **not** refer to a single canonical molecular target but rather describes the **immunomodulatory function** exerted by mesenchymal stem cells (MSCs) through their secretion of anti-inflammatory cytokines. Upon exposure to inflammatory signals at sites of tissue injury or immune activation, MSCs secrete factors such as interleukin 10 (IL‑10), transforming growth factor beta (TGF‑β), prostaglandin E2 (PGE2), indoleamine 2,3-dioxygenase (IDO), nitric oxide (NO), among others. These secreted molecules act on various components of both the innate and adaptive immune systems—including T lymphocytes, dendritic cells, macrophages/NK cells—to suppress excessive inflammation while promoting tissue repair. The effect is highly context-dependent and regulated by local microenvironmental cues including proinflammatory cytokines like IFNγ and TNFα.[1][2][3] This process is being explored therapeutically for conditions characterized by pathological inflammation such as graft-versus-host disease and severe viral infections.[3] However, because this is not an individual molecule/receptor/enzyme/transporter but rather a complex cellular function involving many mediators acting together,[4] it should not be considered a canonical druggable "target" per standard pharmacological definitions. --- **Key note:** The provided name describes an entire *cellular mechanism*—not an individual molecular target—so it does **not conform** to standard conventions for therapeutic targets used in drug discovery databases. If you require structured data on specific molecules involved in this pathway—such as "Transforming growth factor beta receptor," "Indoleamine 2,3-dioxygenase," etc.—those should be listed individually instead.

Other names

Mesenchymal stem cell immunomodulationMSC-mediated anti-inflammatory cytokine secretionMSC immunosuppressionMesenchymal stromal cell immune modulation

The mechanism involves paracrine signaling by secreted cytokines such as IL‑10, TGF‑β, PGE2, IDO; suppression of pro-inflammatory responses; induction of regulatory immune phenotypes in various leukocytes.[1][2][4]